Tumor environment keeps tumor-fighting T cells away

September 19, 2011

Tumors have an arsenal of tricks to help them sidestep the immune system. A study published on September 19 in the Journal of Experimental Medicine reveals a new trick -- the ability to keep tumor-fighting T cells out by disabling a T cell–attracting protein within the tumor core.

The faces many challenges in its attempt to fight off cancer. The tumor itself can promote the generation of naturally suppressive immune cells that keep their tumor-fighting brethren in check. Tumors can also create a hostile environment that hampers T cell function. The hostile environment is caused in part by the production of harmful reactive nitrogen species (RNS) inside the tumor.

RNS trigger the addition of small chemical modifications to proteins in their immediate vicinity. According to the new study, one of these RNS targets is CCL2, a small protein that attracts protective T cells to the tumor. Once modified by RNS, however, CCL2 is invisible to tumor-fighting , which thus remain helplessly outside the tumor margins. By generating a drug that blocks RNS-induced chemical reactions or by injecting unmodified CCL2 into the , the scientists restored the T cells' ability to invade.

If these findings hold up in humans, such RNS-blocking drugs might be combined with current therapies to help eradicate tumors more effectively.

Explore further: Crucial molecule that involved in spread of breast cancer found

More information: Molon, B., et al. 2011. J. Exp. Med. doi:10.1084/jem.20101956

Related Stories

Recommended for you

Shape of tumor may affect whether cells can metastasize

April 28, 2016

Only a few cells in a cancerous tumor are able to break away and spread to other parts of the body, but the curve along the edge of the tumor may play a large role in activating these tumor-seeding cells, according to a new ...

SPF30 sunscreens delay melanoma incidence in preclinical model

April 18, 2016

Application of sun protection factor 30 (SPF30) sunscreen prior to exposure to ultraviolet-B (UVB) light delayed melanoma onset in a mouse model of the disease, according to data from a team at The Ohio State University Comprehensive ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.